Thus, T22-DITOX-H6’s ability to eliminate CXCR4+ cancer cells presenting a more invasive and metastatic phenotype blocks HNSCC’s invasiveness and its metastatic dissemination to the cervical lymph nodes, lungs, and liver, in the absence of histopathological alterations. Here, CXCR4 is linked to head and neck squamous cell carcinoma.